Geode Capital Management’s LYRA THERAPEUTICS INC LYRA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-12,249
| Closed | -$37.7K | – | 4564 |
|
|
2025
Q4 | $37.7K | Buy |
12,249
+1,263
| +11% | +$6.28K | ﹤0.01% | 4284 |
|
|
2025
Q3 | $72.4K | Hold |
10,986
| – | – | ﹤0.01% | 4206 |
|
|
2025
Q2 | $98.5K | Sell |
10,986
-9,334
| -46% | -$77.5K | ﹤0.01% | 4064 |
|
|
2025
Q1 | $128K | Buy |
20,320
+2,601
| +15% | +$24.3K | ﹤0.01% | 3964 |
|
|
2024
Q4 | $183K | Buy |
17,719
+2,351
| +15% | +$25.9K | ﹤0.01% | 3931 |
|
|
2024
Q3 | $198K | Buy |
15,368
+266
| +2% | +$3.91K | ﹤0.01% | 3906 |
|
|
2024
Q2 | $209K | Buy |
15,102
+7,913
| +110% | +$895K | ﹤0.01% | 3891 |
|
|
2024
Q1 | $2.24M | Buy |
7,189
+460
| +7% | +$123K | ﹤0.01% | 3072 |
|
|
2023
Q4 | $1.76M | Buy |
6,729
+555
| +9% | +$100K | ﹤0.01% | 3153 |
|
|
2023
Q3 | $1.21M | Buy |
6,174
+3,197
| +107% | +$572K | ﹤0.01% | 3248 |
|
|
2023
Q2 | $612K | Hold |
2,977
| – | – | ﹤0.01% | 3566 |
|
|
2023
Q1 | $308K | Hold |
2,977
| – | – | ﹤0.01% | 3849 |
|
|
2022
Q4 | $467K | Buy |
2,977
+40
| +1% | +$7.92K | ﹤0.01% | 3689 |
|
|
2022
Q3 | $735K | Buy |
2,937
+527
| +22% | +$156K | ﹤0.01% | 3540 |
|
|
2022
Q2 | $680K | Buy |
2,410
+1,661
| +222% | +$452K | ﹤0.01% | 3589 |
|
|
2022
Q1 | $150K | Buy |
749
+29
| +4% | +$6.37K | ﹤0.01% | 4507 |
|
|
2021
Q4 | $157K | Hold |
720
| – | – | ﹤0.01% | 4578 |
|
|
2021
Q3 | $329K | Sell |
720
-2
| -0.3% | -$756 | ﹤0.01% | 4223 |
|
|
2021
Q2 | $289K | Sell |
722
-1,084
| -60% | -$494K | ﹤0.01% | 4183 |
|
|
2021
Q1 | $1.05M | Buy |
1,806
+436
| +32% | +$272K | ﹤0.01% | 3540 |
|
|
2020
Q4 | $781K | Buy |
1,370
+560
| +69% | +$316K | ﹤0.01% | 3443 |
|
|
2020
Q3 | $452K | Buy |
810
+147
| +22% | +$91.4K | ﹤0.01% | 3454 |
|
|
2020
Q2 | $375K | Buy |
+663
| New | +$485K | ﹤0.01% | 3469 |
|
Other funds holding LYRA
Geode Capital Management's LYRA Position: Q1 2026 in Review
Geode Capital Management sold out of LYRA THERAPEUTICS INC (LYRA) in Q1 2026, closing a stake of 12,249 shares — an estimated $37.7K sold.
Geode Capital Management first reported a position in LYRA in Q2 2020 and held it in 23 quarters. The position peaked at $2.24M in Q1 2024. 1 fund tracked by Wall St. Rank holds LYRA as of Q1 2026.
- Geode Capital Management reported no remaining LYRA THERAPEUTICS INC position as of Q1 2026 after selling out during the quarter.
- Geode Capital Management sold 12,249 LYRA THERAPEUTICS INC shares in Q1 2026, an estimated $37.7K.
- Geode Capital Management first reported a position in LYRA THERAPEUTICS INC in Q2 2020 and held it in 23 quarters.
- Geode Capital Management's LYRA THERAPEUTICS INC position peaked at $2.24M in Q1 2024.
- 1 fund tracked by Wall St. Rank held LYRA THERAPEUTICS INC as of Q1 2026.
Based on Geode Capital Management's 13F filing for Q1 2026, filed 15 May 2026.